Pfizer Bags a New Biosimilar — and a Former Commissioner

Drug Industry Daily
A A
In a big week for Pfizer, the world’s second largest drugmaker earned the FDA’s approval for a biosimilar cancer treatment and signed up the agency’s former Commissioner Scott Gottlieb for its board.

To View This Article:

Login

Subscribe To Drug Industry Daily